CClinicalTrials.gg
RecruitingNCT07642245Updated Jun 11, 2026

Effects of Pilates and Moderate-Intensity Aerobic Exercise on Postpartum Weight Loss and Body Composition

An interventional study of Pilates and Aerobic Exercise in Postpartum Period, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-06-11.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Apr 2025, registered Jun 2026).
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

After childbirth, many women experience difficulty losing pregnancy-related weight, which can affect their health, self-esteem, and physical activity. Regular exercise, including Pilates and moderate-intensity aerobic exercises, is considered a safe and natural method to improve fitness and support weight loss during the postpartum period. This study aims to compare the effects of Pilates and aerobic exercise on body weight, Body Mass Index (BMI), and waist-to-hip ratio in postpartum women over 8 weeks. Participants will be randomly assigned to either a Pilates group or an aerobic exercise group, with both groups exercising three times weekly for 45-60 minutes. The results will then be compared to determine which exercise method is more effective.

Read the detailed description

After childbirth, many women find it hard to lose the extra weight they gained during pregnancy. This weight can affect their health, self-esteem, and ability to stay active. Regular exercise is a safe and natural way to help lose weight and improve fitness during the postpartum period. Two popular forms of exercise are Pilates and moderate-intensity aerobic exercises (like brisk walking or cycling).

This study aims to find out which type of exercise-Pilates or aerobic exercise- is more helpful for postpartum women in reducing body weight, Body Mass Index (BMI), and waist-to-hip ratio over a period of 8 weeks. To do this, women will be randomly divided into two groups. One group will do Pilates exercises, and the other group will do aerobic exercises. Both groups will exercise three times a week for about 45-60 minutes each session. At the end of 8 weeks, the results will be compared to see which type of exercise is more effective.

02

Conditions studied

  • Postpartum Period

Keywords

  • Aerobic Exerciser
  • Body Mass Index
  • Exercise Therapy
  • Pilates
03

In context

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women aged 20 to 40 years
  • BMI > 25kg/m2 at baseline
  • Medically cleared by a health professional to perform physical activity
  • Women 6 to 24 weeks postpartum

Exclusion criteria

Exclusion Criteria:

  • Women with complications during delivery (Cesarean complications, perineal tears grade 3 or 4)
  • Presence of chronic disorders (diabetes mellitus, cardiovascular disorders, severe anemia)
  • Neuromusculoskeletal disorders affecting physical activity
  • Currently participating in another fitness program
  • Postpartum depression or other psychological disorders that may affect adherence
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Group A - Pilates Group

    Type of Exercise: Mat-based Pilates focusing on core stability, breathing control, flexibility, and pelvic floor strengthening

    Other: Pilates

  • Active comparator
    Group B - Aerobic Exercise Group

    Moderate intensity aerobic training (e.g., brisk walking, cycling, or low-impact dance routines) Intensity: 50-70% of maximum heart rate (monitored using Rate of Perceived Exertion Scale 11-13 on Borg Scale)

    Other: Aerobic Exercise

Interventions

  • OtherPilates

    Pilates Group Type of Exercise: Mat-based Pilates focusing on core stability, breathing control, flexibility, and pelvic floor strengthening. Structure: Warm-up (10 mins): Light mobility and breathing exercises; Main Session (30-40 mins): Pelvic tilts, bridging, leg stretches, roll-ups, side-lying series; Focus on posture, controlled movement, and core engagement; Cool-down (5-10 mins): Gentle stretching and relaxation. Progression: Gradual increase in intensity and complexity over 8 weeks. Supervision: Sessions led by a trained physiotherapist or certified Pilates instructor.

  • OtherAerobic Exercise

    Aerobic Exercise Group Type of Exercise: Moderate intensity aerobic training (e.g., brisk walking, cycling, or low-impact dance routines). Intensity: 50-70% of maximum heart rate (monitored using Rate of Perceived Exertion Scale 11-13 on Borg Scale). Structure: Warm-up (10 mins): Marching in place, arm circles, step touch; Main Session (30-40 mins): Rhythmic aerobic routines or treadmill walking; Cool-down (5-10 mins): Stretching major muscle groups. Supervision: Sessions conducted under the guidance of a physiotherapist or fitness instructor.

06

What researchers measure

Primary outcomes

  1. Weight (kilograms) - measured using a calibrated weighing scale

    Measured with a calibrated digital weighing scale. Participants will be weighed barefoot, wearing light clothing, after emptying their bladder. Reliable if calibrated regularly and used under standardized conditions (same scale, same time of day, light clothing, after voiding). Test-retest reliability \> 0.97. Highly valid for measuring body weight; directly measures mass in kilogram. The scale's accuracy is typically within 0.1 kg.

    Time frame: 8 weeks

  2. Body Mass Index (BMI)

    Calculated by dividing weight (kg) by the square of height (m) (BMI = weight/height²). Height will be measured once at baseline with a stadiometer. Reliable when the procedure is standardized (barefoot, standing straight, head in Frankfort plane). Intra-observer reliability \> 0.95. Valid anthropometric tool; stadiometers accurately reflect true stature when calibrated.

    Time frame: 8 weeks

  3. Waist to Hip Ratio (WHR)

    Calculated by dividing Waist by Hip (WHR = Waist cm / Hip cm). Reliable if both waist and hip are measured accurately with the same procedure. WHR is a well validated indicator of body-fat distribution and health-risk; a higher WHR is strongly associated with metabolic disorders

    Time frame: 8 weeks

07

Study locations

1 of 1 sites recruiting
  • Ghurki Teaching Hospital
    Lahore, Punjab Province 54000, Pakistan
    Recruiting
08

References and documents

Publications

  • Seitz D, Hintze A. [Myelomalacia following vertebral angiography with a femoral catheter (author's transl)]. Rofo. 1976 Jul;125(1):59-62. doi: 10.1055/s-0029-1230418. German. PubMed 133946 ↗
  • Goldstein J. Biologic and clinical considerations of hepatitis B infection. J Endod. 1979 Feb;5(2):56-9. doi: 10.1016/S0099-2399(79)80108-9. No abstract available. PubMed 296244 ↗
  • Drake AF, Dufton MJ, Hider RC. The flexible nature of a critical peptide region common to all Elapidae "short" neurotoxins. FEBS Lett. 1977 Nov 15;83(2):202-6. doi: 10.1016/0014-5793(77)81005-3. No abstract available. PubMed 590500 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07642245
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jun 11, 2026
Start date
Apr 2, 2025
Primary completion
Sep 2, 2026 (estimated)
Completion
Oct 15, 2026 (estimated)
Last update
Jun 11, 2026

Study contacts

Imran Amjad, PHD*
Contact
imran.amjad@riphah.edu.pk
03324390125
Imran Amjad, PHD*
Contact
imran.amjad@riphah.edu.pk
0515481826
Zainab Nadeem, MS*
principal investigator · Riphah International University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion